An improvement to the macro outlook on a COVID-19 vaccine could hurt the appraisals, if not the profits, of tech services, according to analysts.
Read More
An improvement to the macro outlook on a COVID-19 vaccine could hurt the appraisals, if not the profits, of tech services, according to analysts.
Read More